Literature DB >> 7977652

The T cell antigen receptor CD3:CD4 molecular complex is diminished on the surface of pulmonary lymphocytes.

K Marathias1, C Pinto, G Rodberg, F Preffer, J Wong, R Kradin.   

Abstract

CD4, a 55-kd cell surface glycoprotein, binds to class II major histocompatibility complex (MHC) (Ia) antigens and functions as a coreceptor for the T cell antigen receptor (Ti alpha beta)-CD3 complex. We have observed that critical elements of the T cell antigen multireceptor complex, including Ti alpha beta, CD3, CD4, but not CD8, were diminished on CD45RO+ pulmonary T lymphocytes but not CD45RO+ peripheral blood T lymphocytes (PBL). Epitopes mapping from the first (D1) to the fourth (D4) extracytoplasmic Ig-like domains of CD4 were expressed to a lesser degree on pulmonary T cells than on PBL (P = 0.002). CD4 expression on pulmonary T cells did not increase after 72 hours of ex vivo culture in complete medium but was restored toward control levels by stimulation with phytohemagglutinin, anti-CD3, or interleukin-2. CD4 mRNA isolated from lung T cells and PBL co-migrated on Northern blots and the total levels of CD4 mRNA were comparable, suggesting that diminished CD4 expression by pulmonary T cells might reflect a posttranscriptional change. To determine whether CD4bright T cells convert with mitogen stimulation to CD4dim cells, PBLs were stimulated with immobilized anti-CD3, anti-CD4, or a molecularly engineered anti-CD3:CD4 bispecific monoclonal antibody and the ratio of the CD4:CD3 mean fluorescence staining intensities was calculated at days 3 and 13. The CD4:CD3 ratio decreased primarily for cells stimulated with anti-CD3:CD4, suggesting that co-ligation of CD3 and CD4 is required for the generation of CD4dim T cells. We conclude that diminished Ti alpha beta-CD3:CD4 expression is a characteristic of T cells in lung that is not shared by peripheral blood T cells in vivo, and speculate that this change reflects T cell activation in a millieu of limited interleukin-2 availability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977652      PMCID: PMC1887433     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120.

Authors:  M Merkenschlager; D Buck; P C Beverley; Q J Sattentau
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

2.  T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.

Authors:  M Merkenschlager; D M Altmann; H Ikeda
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

Review 3.  Interactions of HIV gp120 with the CD4 molecule on lymphocytes and in the nervous system.

Authors:  Q J Sattentau
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 4.  The gp120-CD4 interface: structural, immunological and pathological considerations.

Authors:  T Kieber-Emmons; B A Jameson; W J Morrow
Journal:  Biochim Biophys Acta       Date:  1989-12-27

Review 5.  Mutational analysis of the structure and function of the CD4 protein.

Authors:  C Doyle; J Shin; R L Dunbrack; J L Strominger
Journal:  Immunol Rev       Date:  1989-06       Impact factor: 12.988

6.  Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis.

Authors:  T Mizukami; T R Fuerst; E A Berger; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.

Authors:  S M Schnittman; H C Lane; J Greenhouse; J S Justement; M Baseler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  Lymphocyte surface marker expression in rheumatic diseases: evidence for prior activation of lymphocytes in vivo.

Authors:  M D Smith; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

9.  Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens.

Authors:  M Streuli; C Morimoto; M Schrieber; S F Schlossman; H Saito
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

10.  Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung.

Authors:  C Saltini; M Kirby; B C Trapnell; N Tamura; R G Crystal
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more
  1 in total

1.  Resiquimod and polyinosinic-polycytidylic acid formulation with aluminum hydroxide as an adjuvant for foot-and-mouth disease vaccine.

Authors:  Chun-Xue Zhou; Dong Li; Ying-Li Chen; Zeng-Jun Lu; Pu Sun; Yi-Mei Cao; Hui-Fang Bao; Yuan-Fang Fu; Ping-Hua Li; Xing-Wen Bai; Bao-Xia Xie; Zai-Xin Liu
Journal:  BMC Vet Res       Date:  2014-01-03       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.